Get the latest Science News and Discoveries

Lundquist investigator Dr. Ashraf Ibrahim is the lead author in the landmark study on pioneering oral fungal infection ... - EurekAlert


A novel oral amphotericin B (MAT2203) developed by Matinas BioPharma for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies. The groundbreaking research, led by Lundquist Institute (TLI) Investigator Ashraf Ibrahim, PhD, has been published in the journal <em>Antimicrobial Agents and Chemotherapy</em>.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of lead author

lead author

Photo of Ashraf Ibrahim

Ashraf Ibrahim

Photo of Dr. Ashraf

Dr. Ashraf

Related news:

News photo

The carbon emissions of academic astronomy - EurekAlert

News photo

Elucidating the role of a shared lncRNA-miRNA-mRNA network in exacerbating Parkinson's disease symptoms in the ... - EurekAlert

News photo

Unlocking the genetic mysteries behind plant adaptation: New insights into the evolution of a water-saving trait in the ... - EurekAlert